Bajaj Healthcare shares jumped more than 6% after the company entered into a development and supply agreement with a European entity.
After its development, this API will be initially supplied in small amounts and used by the EU partner to conduct clinical trials for an alternative indication.
In the exchange filing the company also shared, “The trust reposed in our Company by the EU partner for sourcing clinical trial quantities is a testimony of the Company’s development and manufacturing capabilities along with the Good Manufacturing Practices (GMP) compliance at Company’s manufacturing units.”
As of 12:36 pm, Bajaj Healthcare shares were trading 6.50% higher at Rs 403.00 on the NSE.
